8-K: Team Inc. Secures $75M Equity Investment from Stellex

Team, Inc. announced a $75 million private placement of preferred stock and warrants to Stellex Capital Management LLC, significantly reducing debt and enhancing financial flexibility.

Summary

• Team, Inc. completed a private placement of $75 million in Series B Preferred Stock and warrants to InspectionTech Holdings LP, an affiliate of Stellex Capital Management LLC.
• The transaction involved issuing 75,000 shares of Series B Preferred Stock (par value $100.00 per share) and warrants to purchase 982,371 shares of common stock (Tranche A Warrants) at an initial exercise price of $23.00 per share, and 470,889 shares of common stock (Tranche B Warrants) at an initial exercise price of $50.00 per share.
• Proceeds were used to repay $25.0 million of loans under the ABL Credit Agreement and approximately $42.9 million of loans (including accrued interest) under the Second Lien Term Loan Agreement, totaling approximately $67.9 million in debt reduction.
• The ABL Credit Facility was amended to increase commitments from $130.0 million to $150.0 million, reduce the applicable interest rate margin by a range of 0.25% to 0.375% per annum, and extend the maturity date from September 30, 2027, to October 2, 2028.
• The First Lien Term Loan Facility was amended to reduce the applicable interest rate margin by 0.25% per annum and increase the maximum permitted First Lien Net Leverage Ratio to 6.00 to 1.00 through December 31, 2026.
• The Second Lien Term Loan Agreement was amended to increase the maximum permitted First Lien Net Leverage Ratio to 6.50 to 1.00 through December 31, 2026.
• A delayed draw option allows Team, Inc. to issue up to an additional $30.0 million in Series B Preferred Stock and corresponding warrants to Stellex prior to September 11, 2027, in minimum increments of $5.0 million, subject to certain conditions including a First Lien Net Leverage Ratio of 6.50 to 1.00.
• Stellex will have the right to nominate two independent directors to the Board of Directors.
• Existing shareholders (Corre Holders) entered into a voting and support agreement to vote in favor of the issuance of warrant shares and other transaction proposals.

Sentiment

Score: 8

Explanation: The transaction significantly de-leverages the company, improves liquidity, and secures a strategic partner for future growth initiatives. The reduction in interest costs and extended debt maturity are strong positives. While the preferred stock carries a high dividend and governance rights are granted, these are acceptable trade-offs for the financial stability and growth capital provided.

Positives

• Secured $75 million in new capital from a strategic partner, Stellex Capital Management LLC.
• Reduced outstanding debt by approximately $67.9 million, strengthening the balance sheet.
• Increased ABL Credit Facility commitments by $20 million, from $130 million to $150 million.
• Reduced interest rate margins on both ABL Credit Facility (0.25% to 0.375%) and First Lien Term Loan Facility (0.25%).
• Extended ABL Credit Facility maturity date to October 2028, providing longer-term liquidity.
• Enhanced financial flexibility with a delayed draw option for up to an additional $30 million.
• Stellex, as a new partner, is aligned with management's value creation plan and focus on employee development.

Negatives

• Series B Preferred Stock accrues cumulative dividends at 10.5% per annum, payable in kind (increasing stated value) or cash, which can dilute common shareholders or increase debt.
• Exercise prices for Tranche A Warrants ($23.00) and Tranche B Warrants ($50.00) may be significantly higher than current market price, indicating a long-term view or high hurdle for profitability for warrant holders.
• Failure to obtain shareholder approval for warrant issuance after the 2026 Annual Meeting will increase the preferred stock return rate by 1% per annum.
• Preferred Stock is redeemable at the company's option after March 11, 2029, at a premium (140% of Initial Stated Value for 42 months), or mandatorily redeemable by holders after December 31, 2030, at a premium, potentially creating future cash obligations.
• The company's ability to make certain restricted payments (e.g., dividends on common stock) is constrained by covenants in the Series B Preferred Stock Certificate of Designation.
• Stellex has significant governance rights, including the right to nominate two independent directors and consent rights over certain corporate actions.
• The voting and support agreement with Corre Holders limits their ability to transfer shares and mandates voting in favor of transaction proposals, potentially reducing shareholder autonomy.

Risks

• Shareholder Dilution: Exercise of warrants and compounding of preferred stock dividends could dilute common shareholders.
• Increased Debt Burden: While immediate debt is reduced, the preferred stock and potential delayed draws represent future obligations that could increase leverage.
• Financial Covenants: The company must maintain compliance with revised First Lien Net Leverage Ratios (max 6.00:1.00 through Dec 31, 2026, then 5.50:1.00 for First Lien; max 6.50:1.00 through Dec 31, 2026, then 6.00:1.00 for Second Lien).
• Shareholder Approval Risk: Failure to obtain shareholder approval for warrant issuance will increase the preferred stock dividend rate.
• Redemption Obligations: Future mandatory redemption rights for preferred stock holders could create significant cash outflow requirements.
• Liquidity Risk for Delayed Draw: The delayed draw option is subject to conditions, including pro forma compliance with a First Lien Net Leverage Ratio of 6.50 to 1.00, which might limit access to capital if financial performance deteriorates.
• Operational Risks: Forward-looking statements are subject to 'known and unknown factors that could cause actual results or outcomes to differ materially,' including ability to generate cash flow, access credit, maintain covenant compliance, and impacts from external events (accidents, weather, pandemics, inflation).
• Litigation Risk: The company is subject to 'Specified Litigation' which could result in judgments or orders for payment of money exceeding $10,000,000.

Future Outlook

Management expects the transaction to accelerate the execution of its long-term strategic plan focused on top-line growth, lowering the cost structure, and strengthening cash flow. The delayed draw option provides additional capital for permitted acquisitions, growth initiatives, and the company's transformation plan.

Management Comments

• Since 2022, our management team has been keenly focused on successfully executing our strategic roadmap designed to simplify the business, optimize the cost structure, strengthen the balance sheet and drive top-line growth. We've made significant progress towards these goals and today, we are pleased to announce a $75 million preferred stock investment with Stellex, which materially strengthens our balance sheet, reduces our debt, and will help fund our ongoing transformation.
• The targeted enhancements to our existing ABL and First Lien Facilities highlight the benefits of this strategic investment by boosting accessibility and lowering pricing. This helps position TEAM to accelerate execution of our long-term strategic plan focused on top-line growth, lowering our cost structure and strengthening our cash flow. We are excited to partner with Stellex and appreciate their confidence in our value creation plan. We also want to thank Eclipse, HPS and Corre for their continued support and confidence in TEAM.
• We are pleased to partner with TEAM at a pivotal moment in its evolution. We believe TEAM is built on strong fundamentals, and we see a compelling opportunity towards further unlocking its meaningful growth potential through strengthening the Company's capital structure. This investment represents more than just capital – it is a shared commitment to accelerating operational distinction, advancing technology, and delivering long-term value to TEAM's customers and shareholders. Just as importantly, we recognize that TEAM's employees are integral to its success, and we are aligned with TEAM's focus on employee development and making TEAM the employer of choice. We look forward to supporting the Company as it seeks to scale its capabilities and build for the future.

Industry Context

The transaction provides Team, Inc. with crucial capital and improved debt terms, positioning it to pursue strategic growth and operational efficiency in the specialty industrial services sector. This move is indicative of companies in capital-intensive industries seeking strategic partners to de-leverage and fund transformation initiatives amidst evolving market conditions. The involvement of a private equity firm like Stellex suggests a belief in the long-term value creation potential through operational improvements and strategic expansion.

Comparison to Industry Standards

• The reduction in applicable interest rate margins on the ABL and First Lien facilities (0.25% to 0.375% and 0.25% respectively) suggests improved creditworthiness or favorable market conditions for the company's debt profile, potentially aligning with or exceeding industry averages for companies undertaking similar financial restructuring.
• The extension of the ABL facility maturity to October 2028 provides longer-term liquidity, which is generally a positive indicator compared to shorter-term debt structures common in distressed or highly leveraged companies.
• The 10.5% annual return rate on Series B Preferred Stock, payable in kind or cash, is a significant cost of capital, but may be competitive for preferred equity financing in the current market for companies undergoing transformation, especially given the warrant component.
• The First Lien Net Leverage Ratio covenants (max 6.00:1.00 through Dec 2026, then 5.50:1.00) and Second Lien First Lien Net Leverage Ratio covenants (max 6.50:1.00 through Dec 2026, then 6.00:1.00) provide specific benchmarks for the company's leverage, which can be compared to industry peers to assess relative financial health and risk tolerance.

Management Changes

Corporate Governance

Legal Proceedings

• The filing mentions 'Specified Litigation', referring to the Kelli Most litigation proceedings disclosed in Note 16 of the company's most recent Form 10-Q.
• The company must provide prompt notice of any material change in connection with this litigation and copies of non-confidential pleadings or final settlement agreements.
• A 'Specified Litigation Reserve' is established, net of independent third-party insurance, for outstanding and unpaid monetary settlements or judgments.

Related Party Transactions

• Issuance of Series B Preferred Stock and warrants to InspectionTech Holdings LP, an affiliate of Stellex Capital Management LLC.
• Voting and Support Agreement with Corre Opportunities Qualified Master Fund, LP, Corre Horizon Fund, LP, and Corre Horizon II Fund, LP (Corre Holders), who are existing shareholders.
• Stellex Capital Management LLC (Stellex) and Corre Partners Management, LLC (Corre) are defined as 'Affiliates' for certain purposes in the loan documents, indicating ongoing relationships.
• Management or similar fees payable to Designated Equity Investor (Corre) or Stellex or their affiliates are restricted but permitted under certain conditions after a Qualified Change of Control Transaction or Stellex Change of Control Transaction.

Stakeholder Impact

• Shareholders: Potential dilution from preferred stock dividends and warrant exercise, but also benefit from reduced debt and enhanced financial stability. Common shareholders' voting power is influenced by the voting agreement with Corre Holders.
• Employees: Management comments highlight a focus on employee development and making the company an 'employer of choice', suggesting potential positive impacts on employee morale and retention.
• Customers: The transaction aims to accelerate operational distinction and advance technology, which could lead to improved services and long-term value for customers.
• Creditors (ABL, First Lien, Second Lien): Benefit from significant debt reduction, improved financial covenants, reduced interest margins, and extended maturity dates, indicating a stronger financial position for the company to meet its obligations.

Next Steps

• Obtain shareholder approval for the issuance of warrant shares at future annual meetings.
• Potentially draw upon the additional $30 million delayed draw option for acquisitions and growth initiatives.
• Implement the mutually agreed transformation plan.
• File a resale registration statement for the warrant shares by October 14, 2025.
• Appoint two qualified nominees of Stellex to the Board of Directors.

Key Dates

Recommendation

The capital injection and debt reduction are positive steps towards stabilizing the company's financial position and funding its transformation plan. The improved credit terms and extended maturities provide much-needed breathing room. However, the high cost of preferred equity, potential future redemption obligations, and the significant governance rights granted to Stellex introduce new complexities and potential future pressures. The stock is likely to see some positive movement due to the de-leveraging, but the long-term outlook depends heavily on the successful execution of the transformation plan and the ability to manage the preferred equity burden. A 'hold' recommendation reflects the balance of these positive and negative factors, suggesting investors monitor the execution of the strategic plan and the impact of the new capital structure.

Keywords

Team Inc., TISI, SEC Filing, 8-K, Private Placement, Preferred Stock, Warrants, Stellex Capital Management, Debt Reduction, ABL Facility, First Lien Term Loan, Corporate Governance, Financial Flexibility, Capital Raise, Shareholder Agreement, Anti-Dilution, Risk Management